Ampicillin sulbactam compatibility reconstitution and stability: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Ampicillin sulbactam}} {{CMG}} ==References== {{Reflist}} {{FDA}} Category:Antibiotics Category:Wikinfect") |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Compatibility, Reconstitution and Stability== | |||
When concomitant therapy with aminoglycosides is indicated, ampicillin/sulbactam and aminoglycosides should be reconstituted and administered separately, due to the in vitro inactivation of aminoglycosides by any of the aminopenicillins.<ref>{{Cite web | last = | first = |title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050608s040lbl.pdf |url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050608s040lbl.pdf | publisher = |date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Revision as of 18:01, 16 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Compatibility, Reconstitution and Stability
When concomitant therapy with aminoglycosides is indicated, ampicillin/sulbactam and aminoglycosides should be reconstituted and administered separately, due to the in vitro inactivation of aminoglycosides by any of the aminopenicillins.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050608s040lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.